Form 8-K - Current report:
SEC Accession No. 0001193125-24-157366
Filing Date
2024-06-07
Accepted
2024-06-07 16:15:01
Documents
14
Period of Report
2024-06-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d838967d8k.htm   iXBRL 8-K 42749
2 EX-3.1 d838967dex31.htm EX-3.1 4773
  Complete submission text file 0001193125-24-157366.txt   176751

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA svra-20240606.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20240606_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20240606_pre.xml EX-101.PRE 11716
18 EXTRACTED XBRL INSTANCE DOCUMENT d838967d8k_htm.xml XML 3877
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 241029573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)